← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2011Last known activity
Oct 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT05565820CollaboratorN/AOct 31, 2022
- NCT05565820Overall official - principal investigatorN/AOct 31, 2022
- NCT02624843Overall official - principal investigatorPhase 3Aug 1, 2015
- NCT02624843CollaboratorPhase 3Aug 1, 2015
- NCT01514513Overall official - principal investigatorN/AAug 1, 2011
- NCT01514513Lead sponsorN/AAug 1, 2011
Details
- Last known activity
- Oct 31, 2022